Sign In
Buy GSK
$51.46
-0.0700 (-0.136%)
At Close: Aug 05, 2026
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
10:33am, Friday, 05'th Jan 2024
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Sleeper Hits: 3 Unexpected Stocks Poised for a Breakout in 2024
06:12am, Friday, 05'th Jan 2024
Wall Street's views on stocks and sectors can change tremendously in a short time. For example, in early 2022, the Street was sure that Luckin Coffee (OTC: LKNCY ) was dead and buried.
GSK gets shot in arm from upgrade, AstraZeneca mixed reviews after China deal
06:36am, Wednesday, 03'rd Jan 2024
GSK PLC (LSE:GSK, NYSE:GSK) shares got a shot in the arm this morning after Jefferies took a more positive view of the pharmaceuticals giant. The US investment bank upgraded its rating to ‘buy' fr
GSK (GSK) Rises As Market Takes a Dip: Key Facts
07:33pm, Tuesday, 02'nd Jan 2024
GSK (GSK) concluded the recent trading session at $37.51, signifying a +1.21% move from its prior day's close.
AbbVie Vs. GSK: Dual Dominance In Pharma
04:18am, Saturday, 23'rd Dec 2023
AbbVie and GSK are both solid investment choices in the biopharmaceutical industry. AbbVie's financials and forward outlook show strong performance alongside solid partnerships, which hint at growth p
GSK, Amneal, Kaléo delist patents from FDA's orange book
12:15pm, Friday, 22'nd Dec 2023
Pharmaceutical companies, GSK (GSK), Amneal Pharmaceuticals (AMRX) and Kaléo have agreed to delist some of their patents from the FDA's orange book. GSK withdrew four inhaler patents and Amneal withd
3 Growth at a Reasonable Price (GARP) Stocks for Balanced Growth
11:36am, Friday, 22'nd Dec 2023
Growth at a reasonable price (GARP) stocks represent a middle ground between growth stocks with high valuations and very conservative value stocks. While growth stocks with high valuations could easil
GSK, Hansoh Ink Deal to Develop Lung Cancer ADC Candidate
12:47pm, Thursday, 21'st Dec 2023
GSK enters into an exclusive licensing agreement with China-based Hansoh to develop and commercialize the latter's lung cancer candidate, HS-20093.
GSK agrees to pay up to $1.7 billion for antibody-drug conjugate
08:10am, Wednesday, 20'th Dec 2023
GSK PLC GSK, +0.11% said Wednesday that it has agreed to pay $185 million up front and up to $1.525 billion in success-based milestone payments to license an antibody-drug conjugate from Chinese bioph
5 Big Drug Stocks That May Continue to Outperform in 2024
10:31am, Monday, 18'th Dec 2023
Novo Nordisk (NVO), Eli Lilly (LLY), Vertex Pharmaceuticals (VRTX), Regeneron (REGN) and GSK (GSK) have been performing well this year. These stocks are poised to keep the momentum alive in 2024.
GSK drug combination significantly improves survival in women with a hard-to-treat form of endometrial cancer
03:00am, Monday, 18'th Dec 2023
GSK PLC (LSE:GSK, NYSE:GSK) said its cancer immuno-therapy Jemperli had shown promise when used in harness with an existing cancer drug Zejula when treating advanced or recurrent endometrial forms
GSK (GSK) Beats Stock Market Upswing: What Investors Need to Know
07:32pm, Thursday, 14'th Dec 2023
GSK (GSK) concluded the recent trading session at $36.98, signifying a +0.65% move from its prior day's close.
GSK get European green light for endometrial cancer treatment
02:59am, Monday, 11'th Dec 2023
GSK PLC (LSE:GSK, NYSE:GSK) said the European Commission had granted marketing authorization for Jemperli (dostarlimab) in combination with chemotherapy for the treatment of advanced or recurrent en
Glaxo (GSK) Upgraded to Buy: What Does It Mean for the Stock?
01:32pm, Monday, 04'th Dec 2023
Glaxo (GSK) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
GSK vs. VRTX: Which Stock Should Value Investors Buy Now?
12:47pm, Monday, 04'th Dec 2023
Investors with an interest in Medical - Biomedical and Genetics stocks have likely encountered both GSK (GSK) and Vertex Pharmaceuticals (VRTX). But which of these two stocks offers value investors a
